Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The lipid flippase SLC47A1 blocks metabolic vulnerability to ferroptosis
Zhi Lin, Jiao Liu, Fei Long, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Copper metabolism in cell death and autophagy
Qian‐Li Xue, Rui Kang, Daniel J. Klionsky, et al.
Autophagy (2023) Vol. 19, Iss. 8, pp. 2175-2195
Open Access | Times Cited: 299
The cell biology of ferroptosis
Scott J. Dixon, James A. Olzmann
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 6, pp. 424-442
Closed Access | Times Cited: 294
Regulation of ferroptosis by lipid metabolism
Lauren E. Pope, Scott J. Dixon
Trends in Cell Biology (2023) Vol. 33, Iss. 12, pp. 1077-1087
Closed Access | Times Cited: 220
A guideline on the molecular ecosystem regulating ferroptosis
Enyong Dai, Xin Chen, Andreas Linkermann, et al.
Nature Cell Biology (2024) Vol. 26, Iss. 9, pp. 1447-1457
Closed Access | Times Cited: 74
Oxidative cell death in cancer: mechanisms and therapeutic opportunities
Xiaoqin An, Wenfeng Yu, Jinbao Liu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 64
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function
Matteo Morotti, Alizée J. Grimm, Helen Carrasco Hope, et al.
Nature (2024) Vol. 629, Iss. 8011, pp. 426-434
Open Access | Times Cited: 62
Autophagy-Dependent Ferroptosis in Cancer
Fangquan Chen, Xiutao Cai, Rui Kang, et al.
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 1-3, pp. 79-101
Closed Access | Times Cited: 61
An integrated view of lipid metabolism in ferroptosis revisited via lipidomic analysis
Jong Woo Kim, Ji-Yoon Lee, Mihee Oh, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 8, pp. 1620-1631
Open Access | Times Cited: 54
Tubastatin A potently inhibits GPX4 activity to potentiate cancer radiotherapy through boosting ferroptosis
Shan Liu, Hai‐Liang Zhang, Jing Li, et al.
Redox Biology (2023) Vol. 62, pp. 102677-102677
Open Access | Times Cited: 53
Ferroptosis in immunostimulation and immunosuppression
Daolin Tang, Guido Kroemer, Rui Kang
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 199-210
Open Access | Times Cited: 52
Ferroptosis: principles and significance in health and disease
Fangquan Chen, Rui Kang, Daolin Tang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 51
Ferroptotic therapy in cancer: benefits, side effects, and risks
Jiandong Diao, Yuanyuan Jia, Enyong Dai, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 28
ATF4 in cellular stress, ferroptosis, and cancer
Hu Tang, Rui Kang, Jiao Liu, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 4, pp. 1025-1041
Closed Access | Times Cited: 27
Metabolism-regulated ferroptosis in cancer progression and therapy
Lvlan Ye, Xiangqiong Wen, Jiale Qin, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 25
Progress and Challenges in Tumor Ferroptosis Treatment Strategies: A Comprehensive Review of Metal Complexes and Nanomedicine
Yanhong Su, Bing Liu, Binghan Wang, et al.
Small (2024) Vol. 20, Iss. 25
Closed Access | Times Cited: 19
Metal-phenolic nanocatalyst rewires metabolic vulnerability for catalytically amplified ferroptosis
Yang Zhu, Xuegang Niu, Tiantian Wu, et al.
Chemical Engineering Journal (2024) Vol. 485, pp. 150126-150126
Closed Access | Times Cited: 16
Ferroptosis in ulcerative colitis: Potential mechanisms and promising therapeutic targets
Dan Long, Chenhan Mao, Yingtao Huang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116722-116722
Open Access | Times Cited: 16
S100P is a ferroptosis suppressor to facilitate hepatocellular carcinoma development by rewiring lipid metabolism
Min Yang, Weiwei Cui, Xiaoting Lv, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
The lipid basis of cell death and autophagy
Zhi Lin, Fei Long, Rui Kang, et al.
Autophagy (2023) Vol. 20, Iss. 3, pp. 469-488
Open Access | Times Cited: 40
Ferroptosis: Promising approach for cancer and cancer immunotherapy
Shuyue Zheng, Xin‐Yuan Guan
Cancer Letters (2023) Vol. 561, pp. 216152-216152
Closed Access | Times Cited: 39
Ferroptosis inhibition by oleic acid mitigates iron-overload-induced injury
Josiane Mann, Eduard Reznik, Melania Santer, et al.
Cell chemical biology (2023) Vol. 31, Iss. 2, pp. 249-264.e7
Closed Access | Times Cited: 31
Ferroptosis in hepatocellular carcinoma: from bench to bedside
Daolin Tang, Guido Kroemer, Rui Kang
Hepatology (2023) Vol. 80, Iss. 3, pp. 721-739
Closed Access | Times Cited: 29
Ferroptosis in gastrointestinal cancer: from mechanisms to implications
Ruoxi Zhang, Rui Kang, Daolin Tang
Cancer Letters (2023) Vol. 561, pp. 216147-216147
Open Access | Times Cited: 26
Multifunctional Sr/Se co-doped ZIF-8 nanozyme for chemo/chemodynamic synergistic tumor therapy via apoptosis and ferroptosis
Aimin Wu, Ming Han, Zihan Ni, et al.
Theranostics (2024) Vol. 14, Iss. 5, pp. 1939-1955
Open Access | Times Cited: 15
Adverse effects of ferroptotic therapy: mechanisms and management
Jiao Liu, Rui Kang, Daolin Tang
Trends in cancer (2024) Vol. 10, Iss. 5, pp. 417-429
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top